U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178808) titled 'PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER' on Sept. 11.
Brief Summary: This is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology apparent peritoneal-surface only metastatic disease.
Study Start Date: April 16, 2021
Study Type: INTERVENTIONAL
Condition:
Gastric Adenocarcinoma
Intervention:
PROCEDURE: Cytoreductive surgery and hyperth...